Management of breakthrough pain in children with cancer

Journal of Pain Research

Volumn 7, Issue , 2014, Pages 117-123

  Friedrichsdorf, Stefan J ^a   Postier, Andrea ^b  

^a CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Adjuvant analgesia; Breakthrough pain; Cancer; Integrative medicine; Opioid; Pediatric

Indexed keywords

AMITRIPTYLINE; DEXAMETHASONE; FENTANYL; FENTANYL CITRATE; GABAPENTIN; HYDROMORPHONE; KETAMINE; LIDOCAINE; MORPHINE; NARCOTIC ANALGESIC AGENT; NORTRIPTYLINE; OXYCODONE; PREGABALIN; TRAMADOL;

ANALGESIA; ANTICHOLINERGIC SYNDROME; ATAXIA; BEDTIME DOSAGE; BEHAVIOR DISORDER; BREAKTHROUGH PAIN; CANCER PAIN; CANCER PATIENT; CHILD; CHILD HEALTH CARE; CHILDHOOD CANCER; CONTINUOUS INFUSION; DIZZINESS; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG DOSE ESCALATION; DRUG DOSE REGIMEN; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; HALLUCINATION; HUMAN; HYPERACTIVITY; MYALGIA; NYSTAGMUS; PAIN ASSESSMENT; PATIENT CONTROLLED ANALGESIA; PATIENT CONTROLLED ANALGESIC INFUSION PUMP; PERIPHERAL EDEMA; PERSONALIZED MEDICINE; REVIEW; RISK BENEFIT ANALYSIS; SEDATION; SOMNOLENCE; THOUGHT DISORDER; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

EID: 84897856973     PISSN: 11787090     EISSN: None     Source Type: Journal    
DOI: 10.2147/JPR.S58862     Document Type: Review

References (20)

1. Portenoy RK, Hagen NA. Breakthrough pain: definition, prevalence and characteristics. Pain. 1990;41:273-281.
2. Portenoy RK, Payne D, Jacobsen P. Breakthrough pain: characteristics and impact in patients with cancer pain. Pain. 1999;81:129-134.
3. Zeppetella G, O'Doherty CA, Collins S. Prevalence and characteristics of breakthrough pain in cancer patients admitted to a hospice. J Pain Symptom Manage. 2000;20:87-92.
4. Mercadante S, Maddaloni S, Roccella S, Salvaggio L. Predictive factors in advanced cancer pain treated only by analgesics. Pain. 1992;50: 151-155.
5. Bruera E, Schoeller T, Wenk R, et al. A prospective multicenter assessment of the Edmonton staging system for cancer pain. J Pain Symptom Manage. 1995;10:348-355.
6. Collins JJ, Weisman SJ. Management of pain in childhood cancer. In: Schechter NL, Berde CB, Yaster M, editors. Pain in Infants, Children, and Adolescents. Philadelphia: Lippincott, Williams & Wilkins; 2003:517-538.
7. Friedrichsdorf S, Finney D, Bergin M, Stevens M, Collins J. Breakthrough pain in children with cancer. J Pain Symptom Manage. 2007;34:209-216.
8. Flogegård H, Ljungman G. Characteristics and adequacy of intravenous morphine infusions in children in a paediatric oncology setting. Med Pediatr Oncol. 2003;40:233-238.
9. Knudsen AK, Brunelli C, S Kaasa S, et al. Which variables are associated with pain intensity and treatment response in advanced cancer patients? Implications for a future classifcation system for cancer pain. Eur J Pain. 2011;15:320-327.
10. World Health Organization. Cancer Pain Relief and Palliative Care in Children. Geneva: WHO; 1998.
11. World Health Organization. Principles of Acute Pain Management for Children. Geneva: WHO; 2012. Available from: http://whqlibdoc.who.int/publications/2012/9789241548120_Guidelines.pdf. Accessed May 15, 2013.
12. Friedrichsdorf S, Kuttner L, Karl H. Pharmacological methods to relieve pain. In: Kuttner L, editor. A Child in Pain: What Health Professionals Can Do to Help. Carmarthen, UK: Crown House Publishing; 2010:221-264.
13. American Pain Society. Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain. 6th ed. Chicago: APS; 2008.
14. Friedrichsdorf S, Postier Nugent A. Management of neuropathic pain in children with cancer. Curr Opin Support Palliat Care. 2013;7: 131-138.
15. George JA, Lin EE, Hanna MN, et al. The effect of intravenous opioid patient-controlled analgesia with and without background infusion on respiratory depression: a meta-analysis. J Opioid Manag. 2010;6:47-54.
16. Borland ML, Jacobs I, Geelhoed G. Intranasal fentanyl reduces acute pain in children in the emergency department: a safety and efficacy study. Emerg Med (Fremantle). 2002;14:275-280.
17. Manjushree R, Lahiri A, Ghosh BR, Laha A, Handa K. Intranasal fentanyl provides adequate postoperative analgesia in pediatric patients. Can J Anaesth. 2002;49:190-193.
18. Borland ML, Bergesio R, Pascoe EM, Turner S, Woodger S. Intranasal fentanyl is an equivalent analgesic to oral morphine in paediatric burns patients for dressing changes: a randomised double blind crossover study. Burns. 2005;31:831-837.
19. Nalamacu S, Rauck R, Dilaha L, Parikh N. Lack of correlation between the dose of fentanyl sublingual spray for breakthrough cancer pain and the dose of around-the-clock opioid for persistent pain. J Pain. 2013;14:S74.
20. Twycross R, Prommer EE, Mihalyo M, Wilcock A. Fentanyl (transmucosal). J Pain Symptom Manage. 2012;44:131-149.